Navigation Links
Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential
Date:12/10/2009

vous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals® and Arena® are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the risk for abuse associated with lorcaserin; the use of abuse liability studies by the FDA and DEA and the significance of such studies in determining post-marketing scheduling and control; the development, advancement, therapeutic indication and use, tolerability, safety, selectivity and efficacy of lorcaserin; lorcaserin's patent coverage; and Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, regulatory authorities may disagree with the assessment of the abuse and other study results or find data from Arena's clinical trials and studies not sufficient for regulatory approval; the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; the timing and ability of Arena to receive regulatory approval for
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015 Depomed, Inc. (NASDAQ: ... two healthcare conferences in June. The 2015 ... the Jefferies conference is scheduled for 3:00 pm EDT (12:00 ... 2015 JMP Securities Life Sciences Conference in New York City.  ... am EDT (8:30 am PDT) Wednesday, June 24, 2015. ...
(Date:5/26/2015)... 2015   Generational Equity , a leading mergers ... to announce the acquisition of its client, Peaks ... Washington , by Mi-Med Supply , headquartered ... 2015. Peaks & Plains is the ... medical, incontinent, nutritional, patient care, and housekeeping equipment to ...
(Date:5/26/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("the ... therapeutics that address unmet medical needs in women,s ... will present at the Marcum MicroCap Conference ... 4:00 PM EDTLocation: , The Grand Hyatt, New ... under  ,Investor, or  click here The ...
Breaking Medicine Technology:Depomed To Present At Healthcare Conferences In June 2Generational Equity Announces the Acquisition of Peaks & Plains Inc. by Mi-Med Supply 2Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2
... VEGAS, Aug. 5, 2011 Jury selection in the second ... has begun in Clark County, Nevada. The Nevada Supreme Court ... when it was determined by the court that nurse David ... Inc., "does not possess the requisite skill, knowledge or experience ...
... NxStage Medical, Inc. (Nasdaq: NXTM ... today announced that Jeffrey H. Burbank, Chief Executive ... participate in the following schedule of investor conferences. ... available at http://www.nxstage.com/ir.cfm at the time ...
Cached Medicine Technology:Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs 2NxStage Announces Third Quarter 2011 Investor Conference Schedule 2
(Date:5/26/2015)... 2015 Bellabeat, a company dedicated ... today announces the LEAF , the latest ... activity and ovulation. The LEAF seamlessly combines a ... technolo- gy, particularly its mechanism for tracking breathing ... with lifestyle data and recommendations through the LEAF ...
(Date:5/26/2015)... 2015 Visiting Nurse Association of Northern NJ ... American Cancer Society’s annual Relay for Life fundraiser. The event ... Mennen Sports Arena, 161 East Hanover Ave, Morristown, NJ. At ... to raise money and awareness to help the ACS support ... to the ACS, it is estimated that more than 1.6 ...
(Date:5/26/2015)... 27, 2015 Readers who struggle with ... help in author Chester Litvin ’s new book, ... Code” (published by Trafford Publishing). , Litvin, who is ... stimulating the brain. This book will guide readers through ... sensory brain cells . He shares his patented ...
(Date:5/26/2015)... 27, 2015 This summer, ChopChop: The ... local communities at key events in Greater Boston with a ... free copies of ChopChop Magazine, healthy snacks and other giveaways ... active. , “We want to get our message of eating ... a memorable and fun way,” explains Sally Sampson, Founder of ...
(Date:5/26/2015)... LA (PRWEB) May 26, 2015 In ... along with her as she writes an unforgettable story ... challenges in her life. The first black student to ... harassed and beaten by some students, treated harshly by ... woman. A motivating personal phone conversation with Dr. Martin ...
Breaking Medicine News(10 mins):Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:North Jersey Home Care Agency Supports Relay for Life Fundraiser 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2
... Dr. Vivien Chen, Professor of Public Health and ... Sciences Center New Orleans, has been awarded a grant ... to rapidly collect and report pediatric cancer cases at ... Disease Control and Prevention awarded the grant. LSUSHC,s ...
... HealthDay Reporter , MONDAY , Oct. 3 (HealthDay News) ... as well as those that combine behavior changes and ... people shed pounds, according to a new review. ... effective for weight loss," said Dr. Erin LeBlanc, an ...
... Oct. 4 (HealthDay News) -- Very premature babies may develop ... neonatal intensive care unit and should receive follow-up care to ... Stressors, ranging from diaper changes to intubation, may contribute to ... published Oct. 4 in Annals of Neurology . ...
... OTTAWA, Oct. 4, 2011 -- The use of long-distance video ... neurologists in large centres provides the same level of care ... new study presented today at the Canadian Stroke Congress. ... of a technology called Telestroke received an important stroke drug, ...
... tours in Afghanistan and Iraq, America must cope with the ... of Post Traumatic Stress Disorder (PTSD) is becoming increasingly expensive, ... tries to heal its psychological wounds. New hope ... Prof. Joseph Zohar of Tel Aviv University,s Sackler Faculty ...
... -- Confirming many elderly patients, worst fears, a national ... event, such as a stroke or hip fracture, can ... alarming, researchers found that direct discharge to a skilled ... hospital stays -- put patients at "extremely high risk" ...
Cached Medicine News:Health News:Grant to LSUHSC Tumor Registry creates pediatric cancer research tool 2Health News:Experts Assess What Works for Weight Loss 2Health News:Experts Assess What Works for Weight Loss 3Health News:Stress May Affect Preemies' Brains, Study Shows 2Health News:Telestroke the next best thing 2Health News:A shot of cortisone stops traumatic stress 2Health News:A shot of cortisone stops traumatic stress 3Health News:Medicare patients at risk of long-term institutionalization after hospital stay 2Health News:Medicare patients at risk of long-term institutionalization after hospital stay 3
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Cable System, designed for ... sublaminar interspinous fixation, non-displaced ... sternotomy closure. Consists of ... complete set of instruments ...
Medicine Products: